Medicine
Tolterodine 2 mg tablet
Tolterodine 2 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25ºC (68º to 77ºF).
Key facts
- Active ingredient (INN)
- Tolterodine
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 10 blister pack, 500 tablets, 60 tablets and 14 more
- Manufacturers
- Unichem LaboratoriesIndiaCamber PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaRising Pharma HoldingsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25ºC (68º to 77ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BD07 Tolterodine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 November 2015
- Identifiers
- RxCUI 855178, 855194DailyMed set ID d27e25b5-5d02-419f-b098-41fb162c5872, 56e62829-5371-416a-90b3-4b6429532d25, f67fce7c-69d3-42ae-8c1d-2e26fd4d7415 +2NDC 0093-0018, 29300-240, 31722-806 +2Application ANDA077006, ANDA205399, ANDA204397 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 31722-806-01 | Camber PharmaceuticalsIndia | 2 August 2021 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 31722-806-02 | Camber PharmaceuticalsIndia | 2 August 2021 |
| 500 tablet, film coated in 1 bottle | 31722-806-05 | Camber PharmaceuticalsIndia | 2 August 2021 |
| 60 tablet, film coated in 1 bottle | 31722-806-60 | Camber PharmaceuticalsIndia | 2 August 2021 |
| 60 tablet, film coated in 1 bottle | 33342-098-09 | Macleods PharmaceuticalsIndia | 8 October 2020 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 33342-098-12 | Macleods PharmaceuticalsIndia | 8 October 2020 |
| 500 tablet, film coated in 1 bottle | 33342-098-15 | Macleods PharmaceuticalsIndia | 8 October 2020 |
| 100 tablet in 1 bottle, plastic | 29300-240-01 | Unichem LaboratoriesIndia | 5 August 2020 |
| 500 tablet in 1 bottle, plastic | 29300-240-05 | Unichem LaboratoriesIndia | 5 August 2020 |
| 30 tablet in 1 bottle, plastic | 29300-240-13 | Unichem LaboratoriesIndia | 5 August 2020 |
| 60 tablet in 1 bottle, plastic | 29300-240-16 | Unichem LaboratoriesIndia | 5 August 2020 |
| 90 tablet in 1 bottle, plastic | 29300-240-19 | Unichem LaboratoriesIndia | 5 August 2020 |
| 100 tablet, film coated in 1 bottle | 16571-127-01 | Rising Pharma Holdings | 24 January 2020 |
| 60 tablet, film coated in 1 bottle | 16571-127-06 | Rising Pharma Holdings | 24 January 2020 |
| 500 tablet, film coated in 1 bottle | 16571-127-50 | Rising Pharma Holdings | 24 January 2020 |
| 500 tablet, film coated in 1 bottle | 0093-0018-05 | Teva Pharmaceuticals | 1 November 2015 |
| 60 tablet, film coated in 1 bottle | 0093-0018-06 | Teva Pharmaceuticals | 1 November 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 March 1998 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tolterodine 2 mg tablet.
Other strengths and forms of Tolterodine
Clinical summary
Tolterodine is a cholinergic muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. It is available as extended-release capsules and tablets for oral use. MedsAcross supplies Tolterodine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TolterodineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Detrol prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Tolterodine 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.